Ampligen: A General Overview and the Plan for ME/CFS & Long Covid


For the second installment in our clinical diagnostics and treatments webinar series, Solve M.E. welcomes two leaders from bio-pharma company AIM ImmunoTech to discuss their plans for clinical studies of their investigational drug Ampligen, in ME/CFS and Long Covid. In addition, Drs. Lapp and Gottschalk will share insights from real-world use of Ampligen to treat […]

Join our $50,000 match and double your impact today

You could fund the next big breakthrough!
Skip to content